This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

United Kingdom | EN-GB

Cortex - Life Sciences Insights

Pia Riemenschneider

DLA Piper

About me

3/17/2025 10:34:00 AM

CJEU clarifies the scope of advertising regarding prescription-only medicinal products

By Pia Riemenschneider

On 27 February 2025, the Court of Justice of the European Union (the “CJEU”) issued its judgment in case C‑517/23 between the...

10/31/2024 10:08:51 AM

DLA Piper Genomics Series: From Gene-Edited Plants to Gene Drives: Unpacking Regulatory Debates

By Mikael Kurki Pia Riemenschneider Lisa Weinekötter

In this two-part article, we delve into the complexities of gene editing in plants and the ongoing EU legislative debates, followed by an...

2/20/2024 3:33:36 PM

Gene drives: Genetic engineering without risk?

By Pia Riemenschneider Elisa Winkels Mikael Kurki

What if a new method of genetic engineering could eliminate life-threatening diseases like malaria? What if we could increase crop yields...

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.